Company Filing History:
Years Active: 2019
Title: Innovations by Brian C. Gilger: Pioneering Sustained Delivery Solutions
Introduction
Brian C. Gilger, located in Raleigh, NC, is an inventor renowned for his contributions to the field of polymer formulations. His work focuses on the development of advanced compositions that enhance the delivery and efficacy of therapeutics. With a single patent to his name, Gilger has made significant strides in creating formulations that are not only innovative but also practical for various medical applications.
Latest Patents
Gilger's patent, titled "Liquid pentablock co-polymer formulations for sustained delivery of therapeutics," showcases his expertise in amphiphilic polymer compositions. The patent details aqueous formulations comprising block co-polymers with specific formulas, including PEG-PCL-PLA-PCL-PEG and PCL-PGA-PEG-PGA-PCL. These biodegradable and stable block co-polymers are designed to interact with a range of biologic or chemical active agents. Furthermore, his formulations enable sustained and continuous release of active ingredients, making them suitable for applications such as artificial tears, joint lubricants, and wound cover adhesives.
Career Highlights
Brian C. Gilger is associated with Inovion, Inc., where he utilizes his knowledge and skills to advance therapeutic delivery methods. Throughout his career, he has focused on the intersection of materials science and drug delivery, aiming to create innovative solutions that address contemporary medical challenges. His dedication to research has played a critical role in enhancing patient care through improved therapeutic options.
Collaborations
During his tenure at Inovion, Gilger has collaborated with talented colleagues, including Poonam R. Velagaleti and Ulrich Grau. Together, they contribute to a vibrant research environment that fosters innovation in polymer science and therapeutic delivery. Their collective efforts aim to push the boundaries of traditional medical treatments by exploring new formulation technologies.
Conclusion
Brian C. Gilger’s work exemplifies the spirit of innovation within the realm of polymer formulations. His patent not only highlights his prowess as an inventor but also underscores the potential for improved therapeutic applications that benefit patients. As he continues his research at Inovion, the impact of his contributions in the field of medicine is likely to grow, paving the way for future developments in sustained delivery systems.